NBIX vs. V
NBIX (Neurocrine Biosciences, Inc.) and V (Visa Inc.) are both stocks. NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while V operates in Credit Services (Financial Services). Over the past 10 years, NBIX returned 12.92%/yr vs 15.64%/yr for V. At a 0.32 correlation, their price movements are largely independent.
Performance
NBIX vs. V - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBIX achieves a 15.01% return, which is significantly higher than V's -8.47% return. Over the past 10 years, NBIX has underperformed V with an annualized return of 12.92%, while V has yielded a comparatively higher 15.64% annualized return.
NBIX
- 1D
- -0.46%
- 1M
- 7.14%
- YTD
- 15.01%
- 6M
- 5.25%
- 1Y
- 30.09%
- 3Y*
- 20.43%
- 5Y*
- 10.63%
- 10Y*
- 12.92%
V
- 1D
- -1.21%
- 1M
- 0.48%
- YTD
- -8.47%
- 6M
- -1.79%
- 1Y
- -12.97%
- 3Y*
- 13.52%
- 5Y*
- 7.39%
- 10Y*
- 15.64%
NBIX vs. V - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 15.01% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
V Visa Inc. | -8.47% | 11.76% | 22.32% | 26.31% | -3.40% | -0.31% | 17.12% | 43.33% | 16.49% | 47.18% |
Correlation
The correlation between NBIX and V is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Mar 20, 2008 | 0.32 |
The correlation between NBIX and V shifts across timeframes, from 0.20 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NBIX:
$6.53
V:
$15.24
NBIX:
24.97
V:
20.98
NBIX:
0.49
V:
1.29
NBIX:
5.38
V:
10.84
NBIX:
$3.10B
V:
$43.03B
NBIX:
$3.05B
V:
$16.94B
NBIX:
$881.20M
V:
$27.63B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBIX vs. V — Risk / Return Rank
NBIX
V
NBIX vs. V - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Visa Inc. (V). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBIX | V | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.55 | ||
| Sortino ratioReturn per unit of downside risk | +2.19 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 0.91 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.45 | -0.64 | +2.09 |
| Martin ratioReturn relative to average drawdown | 3.18 | -1.18 | +4.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBIX | V | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.97 | -0.58 | +1.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 0.33 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.64 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.14 | 0.69 | -0.54 |
Drawdowns
NBIX vs. V - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than V's maximum drawdown of -51.90%. Use the drawdown chart below to compare losses from any high point for NBIX and V.
Loading charts...
Drawdown Indicators
| NBIX | V | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.21% | -51.90% | -45.31% |
Max Drawdown (1Y)Largest decline over 1 year | -20.90% | -20.38% | -0.52% |
Max Drawdown (3Y)Largest decline over 3 years | -42.89% | -20.38% | -22.51% |
Max Drawdown (5Y)Largest decline over 5 years | -42.89% | -28.60% | -14.29% |
Max Drawdown (10Y)Largest decline over 10 years | -46.39% | -36.36% | -10.03% |
Current DrawdownCurrent decline from peak | -2.53% | -13.69% | +11.16% |
Average DrawdownAverage peak-to-trough decline | -43.84% | -8.26% | -35.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.49% | 11.03% | -1.54% |
Volatility
NBIX vs. V - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 10.20% compared to Visa Inc. (V) at 5.74%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than V based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBIX | V | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.20% | 5.74% | +4.46% |
Volatility (6M)Calculated over the trailing 6-month period | 23.64% | 17.50% | +6.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.24% | 22.32% | +8.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.73% | 22.80% | +9.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.15% | 24.47% | +14.68% |
Dividends
NBIX vs. V - Dividend Comparison
NBIX has not paid dividends to shareholders, while V's dividend yield for the trailing twelve months is around 0.81%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
V Visa Inc. | 0.81% | 0.70% | 0.68% | 0.72% | 0.76% | 0.62% | 0.56% | 0.56% | 0.67% | 0.61% | 0.75% | 0.64% |
Financials
NBIX vs. V - Financials Comparison
This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Visa Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NBIX vs. V - Profitability Comparison
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
V - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported a gross profit of -8.90B and revenue of 11.23B. Therefore, the gross margin over that period was -79.3%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
V - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported an operating income of 7.23B and revenue of 11.23B, resulting in an operating margin of 64.4%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
V - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported a net income of 6.02B and revenue of 11.23B, resulting in a net margin of 53.6%.
Frequently Asked Questions
NBIX and V have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIX has higher volatility (10.20%) compared to V (5.74%). In terms of maximum drawdown, NBIX dropped -97.21% vs V's -51.90%.
NBIX currently has the higher Sharpe Ratio (0.97 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NBIX and V
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer